With the advent of new agents targeting CD20, Bruton's tyrosine kinase, and
phosphoinositol-3 kinase for chronic lymphoid leukemia (CLL), more treatment options exist …

The B‐cell receptor signaling pathway, which is critical to the development and maturation of
normal B‐cells, is emerging as an attractive therapeutic target in B‐cell malignancies …

Venetoclax (ABT-199) is a small-molecule selective oral inhibitor of the antiapoptotic protein
Bcl-2 that promotes programmed cell death of chronic lymphocytic leukemia (CLL) cells …

Objectives Our present study has shown a potential role for VEGF‐A‐mediated autocrine
signalling to promote survival and proliferation of SU‐DHL‐6 cells, but the cells could not …

Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma.
Ibrutinib is a first-in-class, oral inhibitor of Bruton's tyrosine kinase which acts by downstream …

In the past decade there has been increased appreciation for the complexity and importance
of post-transcriptional processes that control gene regulation and post-translational …